Serial 90835844
Dead / Abandoned — Abandoned — no statement of use filed (as of 11 Sept 2023)
What this means for you
This application is over — abandoned 11 Sept 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90835844
- Mark type
- Design / logo
- Filed
- 19 Jul 2021
- Published for opposition
- 14 Dec 2021
- Abandoned
- 11 Sept 2023
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical, therapeutic and biopharmaceutical agents for the treatment of cancer, infectious diseases, autoimmune disorders, transplant rejections, and inflammatory diseases; pharmaceutical, therapeutic and biopharmaceutical preparations and substances for the treatment of cancer, infectious diseases, autoimmune disorders, transplant rejections, and inflammatory diseases; biological preparations, namely, antibodies for the treatment of cancer, infectious diseases, autoimmune disorders, transplant rejections, and inflammatory diseases
Owner
- Agenus Inc., Lexington, MA, US
- Agenus Inc., Lexington, MA, US
Prosecution history
- 11 Sept 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 11 Sept 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 08 Feb 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Feb 2023 — SOU EXTENSION 2 GRANTED
- 06 Feb 2023 — SOU EXTENSION 2 FILED
- 06 Feb 2023 — SOU TEAS EXTENSION RECEIVED
- 20 Jul 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Jul 2022 — SOU EXTENSION 1 GRANTED
- 18 Jul 2022 — SOU EXTENSION 1 FILED
- 18 Jul 2022 — SOU TEAS EXTENSION RECEIVED
- 08 Feb 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 14 Dec 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 Dec 2021 — PUBLISHED FOR OPPOSITION
- 24 Nov 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 09 Nov 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER